L. Fredrik Jarskog - Concepedia

Author

L. Fredrik Jarskog

University of North Carolina at Chapel Hill ORCID

Also Known As

Ahn, Sangtae, Browne, Julia, Buchanan, Robert W., Casey, Robin L., Hester, Neil R., Jarskog, L. Fredrik, Jones, Mackenzie T, L F Jarskog, L Fredrik Jarskog, L Jarskog

142

Publications

8.3K

Citations

H-Index

105

Concepts

All Affiliations

University of North Carolina at Chapel Hill Columbia University Australian Catholic University New York State Psychiatric Institute New York Psychoanalytic Society and Institute

About

L. Fredrik Jarskog is an author at University of North Carolina at Chapel Hill specializing in medicine, social sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	46	4.1K
2	Social Sciences	25	31	2.2K
3	Health Sciences	4	4	120
4	Public Health	3	3	597
5	Behavioral Sciences	2	2	88

L. Fredrik Jarskog

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder Diana O. Perkins, Clark Jeffries, L. Fredrik Jarskog, Genome biology	2007	557
Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain Ari Urakubo, L. Fredrik Jarskog, Jeffrey A. Lieberman, Schizophrenia Research InflammationMaternal ImmunizationFetal BrainPathogenesisImmunology	2001	403
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial Karen E. Anderson, David Stamler, Mat D. Davis, The Lancet Psychiatry PsychiatryRehabilitationPharmacotherapyInvoluntary MovementsTardive Dyskinesia	2017	326
Randomized controlled trial of deutetrabenazine for tardive dyskinesia Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser, Neurology	2017	322
Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia Cort A. Pedersen, Clare M. Gibson, Shane W. Rau, Schizophrenia Research PsychiatryPsychotic DisorderPsychotropic MedicationAffective NeurosciencePsychopharmacology	2011	303
Cytokine regulation of apoptosis in fetal substantia nigra cultures L. Fredrik Jarskog, John H. Gilmore Biological Psychiatry InflammationCytokine RegulationReactive Nitrogen SpecieNitrosative StressApoptosis	1996	272
Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood Leisa A. Glantz, John H. Gilmore, Robert M. Hamer, Neuroscience Synaptic PlasticityDevelopmental BiologyBrain FunctionDevelopmental Cognitive NeuroscienceNeuroanatomy	2007	263
Prenatal Infection and Risk for Schizophrenia: IL-1β, IL-6, and TNFα Inhibit Cortical Neuron Dendrite Development John H. Gilmore, L. Fredrik Jarskog, Swarooparani Vadlamudi, Neuropsychopharmacology Brain DevelopmentMedicineImmunologySchizophreniaBrain-immune Interaction	2004	252
Apoptotic Proteins in the Temporal Cortex in Schizophrenia: High Bax/Bcl-2 Ratio Without Caspase-3 Activation L. Fredrik Jarskog, Elzbieta S. Selinger, Jeffrey A. Lieberman, American Journal of Psychiatry	2004	201
Intranasal Oxytocin Blocks Alcohol Withdrawal in Human Subjects Cort A. Pedersen, Kelly L. Smedley, Jane Leserman, Alcoholism Clinical and Experimental Research	2012	194

Page 1